Streetbeat News

Products Services

CHWY

Financial giants have shown a significant bullish interest in Chewy (NYSE:CHWY) options, with 60% of traders being bullish. Analysis of options history revealed 10 unusual trades, with a focus on a price band between $12.5 and $22.5. The largest trades include both calls and puts, with the most notable being a bullish call with a strike price of $17.50. Chewy, a leading e-commerce pet care retailer, reported $10.1 billion in 2022 sales. Currently, CHWY's stock is up by 1.32% at $17.6, with an anticipated earnings release in 14 days.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 5:16 pm

ARKK

ARKW

ROKU

Roku Inc (NASDAQ:ROKU) implemented a mandatory update requiring users to agree to new dispute resolution terms, including forced arbitration, causing user backlash. The update, enforced recently, made devices inoperable until users consented. Users criticized the process for opting out, which involves mailing a written notice. Despite this, Roku reported a 14% year-over-year revenue increase in Q4. The stock is also part of ARK Next Generation Internet ETF (NYSE:ARKW) and ARK Innovation ETF (NYSE:ARKK).

Portfolio Pulse from Anusuya Lahiri

March 06, 2024 | 5:14 pm

AMZN

NVDA

An executive from Amazon Web Services (AWS) has stated that the demand for Nvidia chips is expected to remain high. This statement underscores the ongoing need for Nvidia's technology in cloud computing and AI applications, which are core services provided by AWS.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:00 pm

OOMA

Alliance Global Partners has maintained its Buy rating on Ooma (NYSE:OOMA) but reduced its price target from $16.00 to $14.50. Ooma's shares have risen 1.11% in the last 24 hours to $10.00. A price target of $14.50 represents a 45.0% increase from the current price. Ooma Inc. offers innovative communication solutions and services to small business, home, and mobile users through its hybrid SaaS platform.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 5:00 pm

GOSS

Goldman Sachs has reaffirmed its Buy rating on Gossamer Bio (NASDAQ:GOSS) but reduced its price target from $9.00 to $8.00. Despite this, GOSS shares have risen by 0.69% in the last 24 hours to $1.46. Achieving the new price target would represent a significant increase of 447.95% from the current price. Gossamer Bio is a clinical-stage biopharmaceutical company focusing on immunology, inflammation, and oncology treatments.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 5:00 pm

DYN

Piper Sandler has maintained its Overweight rating on Dyne Therapeutics (NASDAQ:DYN) and increased its price target from $27.00 to $29.00. Despite a slight decrease in share price over the last 24 hours, the new target suggests a potential 12.19% upside. Dyne Therapeutics is a biotech company developing therapies for muscle disorders.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 5:00 pm

KURA

Kura Oncology's stock price increased following the announcement of the first patient being dosed in its trial of KO-2806 plus cabozantinib for renal cell carcinoma.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 4:51 pm

STLA

Stellantis N.V. (NYSE:STLA) has received approval from China's National Development and Reform Commission (NDRC) for a joint venture with Leapmotor to build and sell Leapmotor's electric vehicles outside China. This follows Stellantis' announcement in October 2023 of acquiring a 21% stake in Leapmotor for $1.6 billion, granting Stellantis exclusive rights for Leapmotor's products outside China. The approval comes amid heightened tensions between China and the European Union over EV subsidies.

Portfolio Pulse from Shivani Kumaresan

March 06, 2024 | 4:49 pm

UPST

Upstart Holdings (NASDAQ:UPST) has seen a mix of bullish and bearish options activity, with an equal split between investors' expectations. The options trades focus on a price band between $27.5 and $60.0. Notable trades include both calls and puts with varying sentiments and strike prices around $33.00 and $35.00. Upstart, a provider of AI-enabled lending platforms, is currently trading at $25.07, up 2.7%, and may be approaching oversold territory. Analysts from Piper Sandler and JP Morgan have given the stock Neutral and Underweight ratings, respectively, with target prices of $28 and $24.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 4:45 pm

GBTC

IBIT

Bitcoin ETFs saw record inflows of $648M coinciding with Bitcoin reaching a new all-time high of over $69,000. BlackRock's IBIT ETF experienced a record daily net inflow of $788M, while Grayscale's GBTC ETF saw a net outflow of $332M. This reflects growing investor confidence in Bitcoin and a preference for regulated investment vehicles. The surge in Bitcoin's price and ETF inflows was accompanied by a spike in cryptocurrency trading volumes, with Binance leading the market.

Portfolio Pulse from Murtuza Merchant

March 06, 2024 | 4:41 pm